Free Trial

TerrAscend (OTCMKTS:TSNDF) Trading 0.6% Higher - Time to Buy?

TerrAscend logo with Medical background

TerrAscend Corp. (OTCMKTS:TSNDF - Get Free Report) was up 0.6% during mid-day trading on Friday . The company traded as high as $0.38 and last traded at $0.37. Approximately 247,890 shares were traded during trading, a decline of 61% from the average daily volume of 642,178 shares. The stock had previously closed at $0.37.

Wall Street Analyst Weigh In

Separately, Atb Cap Markets raised TerrAscend from a "hold" rating to a "strong-buy" rating in a research report on Thursday, May 8th.

Check Out Our Latest Stock Analysis on TerrAscend

TerrAscend Stock Up 0.6%

The firm has a market capitalization of $110.63 million, a price-to-earnings ratio of -1.38 and a beta of 1.55. The stock has a 50 day moving average of $0.36 and a 200 day moving average of $0.52. The company has a quick ratio of 0.69, a current ratio of 1.35 and a debt-to-equity ratio of 0.81.

TerrAscend (OTCMKTS:TSNDF - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.05) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.02). The firm had revenue of $71.00 million during the quarter, compared to analyst estimates of $71.63 million. TerrAscend had a negative return on equity of 31.48% and a negative net margin of 23.95%. As a group, analysts expect that TerrAscend Corp. will post -0.14 earnings per share for the current fiscal year.

TerrAscend Company Profile

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

Featured Articles

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines